Skip to main content

Articles

Practice Management

Preparing for Healthcare After COVID-19: New Challenges Facing Payers

Wayne Kuznar

Original Research, Practice Management

Budget Impact Analysis of a Home-Based Nutrition Program for Adults at Risk for Malnutrition

Suela Sulo, PhD, MSc; David Lanctin, MPH; Josh Feldstein, BA; Bjoern Schwander, MA, RN; Jamie Partridge, PhD, MBA; Wendy Landow, MPH; York F. Zöllner, MSc

Opdivo Approved for Advanced Esophageal Squamous-Cell Carcinoma

FDA Approvals, Lung Cancer, Oncology

FDA Approves Cyramza plus Tarceva for First-Line Treatment of Metastatic NSCLC with EGFR Mutation

FDA Approvals, Lung Cancer, Oncology

Opdivo plus Yervoy and Limited Chemotherapy Approved as First-Line Therapy for Metastatic NSCLC, Regardless of PD-L1 Expression

FDA Approvals, Lung Cancer, Oncology

Tecentriq plus Avastin First Immunotherapy Regimen Approved for Metastatic Hepatocellular Carcinoma

ASCO 2020 - Lung Cancer

Impact of Immune-Related Adverse Events on Checkpoint Inhibitor Consolidation Therapy in Stage III NSCLC

ASCO 2020 - Lung Cancer

Characteristics of Patients Who Achieve Long-Term Response with PD-1 Blockade

ASCO 2020 - Lung Cancer

Smoking Cessation and Lung Cancer: Recent Quitters Benefit Too

ASCO 2020 - Lung Cancer

Weekly Epirubicin as Second-Line Therapy for Malignant Pleural Mesothelioma

Page 35 of 244
Results 341 - 350 of 2440